MADRID, Spain—A novel patch-pump capable of delivering subcutaneous furosemide over a 5-hour period results in similar bioavailability and efficacy as an intravenous infusion and is well tolerated by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback